Rankings
▼
Calendar
COLL Q4 2017 Earnings — Collegium Pharmaceutical, Inc. Revenue & Financial Results | Market Cap Arena
COLL
Collegium Pharmaceutical, Inc.
$1B
Q4 2017 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$11M
+728.4% YoY
Gross Profit
$10M
89.9% margin
Operating Income
-$18M
-162.9% margin
Net Income
-$17M
-161.2% margin
EPS (Diluted)
$-0.53
QoQ Revenue Growth
-9.7%
Cash Flow
Operating Cash Flow
-$13M
Free Cash Flow
-$13M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$136M
Total Liabilities
$31M
Stockholders' Equity
$104M
Cash & Equivalents
$119M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$11M
$1M
+728.4%
Gross Profit
$10M
$1M
+766.8%
Operating Income
-$18M
-$28M
+36.2%
Net Income
-$17M
-$28M
+36.9%
← FY 2017
All Quarters
Q1 2018 →